Melita Jung
Corporate Officer/Principal at TERNS PHARMACEUTICALS, INC.
Net worth: - $ as of 2024-03-30
Profile
Melita Sun Jung is currently the Chief Business Officer at Terns Pharmaceuticals, Inc. She previously held positions as the Senior Director-Corporate Development at Adamas Pharmaceuticals LLC from 2014 to 2017, the Head-Business Development at Sangamo Therapeutics, Inc. from 2017 to 2021, and the Vice President-Business Development at Ascendancy Healthcare, Inc. from 2012 to 2014.
She also served as the Chief Business Officer at Structure Therapeutics, Inc. Ms. Jung completed her undergraduate degree at the University of California, Berkeley.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-02-06 | 0 ( -.--% ) | - $ | 2024-03-30 |
Melita Jung active positions
Companies | Position | Start |
---|---|---|
TERNS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2024-04-21 |
Former positions of Melita Jung
Companies | Position | End |
---|---|---|
SANGAMO THERAPEUTICS, INC. | Corporate Officer/Principal | 2020-12-31 |
ADAMAS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2017-05-31 |
Ascendancy Healthcare, Inc.
Ascendancy Healthcare, Inc. Pharmaceuticals: MajorHealth Technology Ascendancy Healthcare, Inc. engages in the commercialization of pharmaceutical productS. It enables product entry by providing clinical, regulatory and commercial expertise and oversight along with funding. The company was founded by Arthur Joseph Higgins and Sanford S. Zweifach on November 21, 2011 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 2014-04-30 |
STRUCTURE THERAPEUTICS INC. | Corporate Officer/Principal | - |
Training of Melita Jung
University of California, Berkeley | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
SANGAMO THERAPEUTICS, INC. | Health Technology |
TERNS PHARMACEUTICALS, INC. | Health Technology |
Private companies | 3 |
---|---|
Adamas Pharmaceuticals LLC
Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. | Health Technology |
Ascendancy Healthcare, Inc.
Ascendancy Healthcare, Inc. Pharmaceuticals: MajorHealth Technology Ascendancy Healthcare, Inc. engages in the commercialization of pharmaceutical productS. It enables product entry by providing clinical, regulatory and commercial expertise and oversight along with funding. The company was founded by Arthur Joseph Higgins and Sanford S. Zweifach on November 21, 2011 and is headquartered in San Francisco, CA. | Health Technology |
Structure Therapeutics, Inc. |
- Stock Market
- Insiders
- Melita Jung